Trial intelligence / Profile preview

Sequential vs Concomitant H. pylori Eradication in Myanmar

NCT04132479Phase 4Completed

Sponsor
The Kirby Institute
Start
Jan 2018
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rabeprazole, amoxicillin, clarithromycin, tinidazole in Helicobacter pylori infection, sponsored by The Kirby Institute. Started Jan 2018; status: completed.

02

Drugs

rabeprazoleamoxicillinclarithromycintinidazole
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT04132479.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04132479.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call